Systemic and cell type-specific gene expression patterns in scleroderma skin.
about
Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunityEvidence by molecular profiling for a placental origin of infantile hemangioma.Current perspectives on the immunopathogenesis of systemic sclerosisGenetics, Epigenetics, and Genomics of Systemic SclerosisScleroderma pathogenesis: a pivotal role for fibroblasts as effector cellsRituximab in diffuse cutaneous systemic sclerosis: should we be using it today?Targeted Therapy in Systemic SclerosisReview: Hematopoietic Stem Cell Transplantation for Scleroderma: Effective Immunomodulatory Therapy for Patients With Pulmonary InvolvementGene expression profiling offers insights into the role of innate immune signaling in SScConnective tissue growth factor overexpression in cardiomyocytes promotes cardiac hypertrophy and protection against pressure overloadA model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients.Dissecting the heterogeneity of skin gene expression patterns in systemic sclerosisEfficient Mining of Discriminative Co-clusters from Gene Expression Data.A methodology for exploring biomarker--phenotype associations: application to flow cytometry data and systemic sclerosis clinical manifestationsMolecular subsets in the gene expression signatures of scleroderma skin.Expression of collagen genes in the cones of skin in the Duroc/Yorkshire porcine model of fibroproliferative scarring.Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle studyLimited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury.Diverse and specific gene expression responses to stresses in cultured human cells.Global chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin.High Rhodotorula sequences in skin transcriptome of patients with diffuse systemic sclerosis.B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trial.Fox-2 protein regulates the alternative splicing of scleroderma-associated lysyl hydroxylase 2 messenger RNAGene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways.Identification of cadherin 11 as a mediator of dermal fibrosis and possible role in systemic sclerosis.Egr-ly awaiting a "personalized medicine" approach to treat scleroderma.Profiling the mitochondrial proteome of Leber's Hereditary Optic Neuropathy (LHON) in Thailand: down-regulation of bioenergetics and mitochondrial protein quality control pathways in fibroblasts with the 11778G>A mutationIdentification of epistatic effects using a protein-protein interaction database.Emerging targets for the treatment of scleroderma.Redirecting valvular myofibroblasts into dormant fibroblasts through light-mediated reduction in substrate modulus.Genome-wide DNA methylation analysis in dermal fibroblasts from patients with diffuse and limited systemic sclerosis reveals common and subset-specific DNA methylation aberrancies.Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis.Systems level analysis of systemic sclerosis shows a network of immune and profibrotic pathways connected with genetic polymorphisms.Experimentally-derived fibroblast gene signatures identify molecular pathways associated with distinct subsets of systemic sclerosis patients in three independent cohorts.Cadherin-11 regulates fibroblast inflammationCanonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma?Matrix contraction by dermal fibroblasts requires transforming growth factor-beta/activin-linked kinase 5, heparan sulfate-containing proteoglycans, and MEK/ERK: insights into pathological scarring in chronic fibrotic disease.Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension.Sustained β-catenin activity in dermal fibroblasts promotes fibrosis by up-regulating expression of extracellular matrix protein-coding genes.B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis
P2860
Q22306446-ED5FC747-396A-457F-BF82-FE40961D366EQ24535837-64C11564-15DB-4300-8425-0BB244322918Q26741264-C8FEFE59-801B-48A1-AC5F-2488D7A2404DQ26799577-3AEC41F5-997B-4955-945A-C4312E7A60DFQ26851971-2DA88CF8-4205-4965-86A2-A0D5DE452667Q27022117-11E42B76-507C-467A-B9CE-0760CBBDDCF0Q28072943-081AE219-901E-428F-9C79-E14107DE34C2Q28080076-A567029D-B5D5-4052-8A4D-E23E851FC6A2Q28083733-D8525268-88AE-4783-80FF-751AE5153F9FQ28575610-1EEA1C2F-5B53-4B96-B880-A216BB3F8994Q30478833-4693679E-CDFD-47A4-B85E-A284223BF224Q30845649-C24C501E-DD8D-46D3-B986-C584C92DA8E5Q30887004-14EDCE1C-9FBC-456C-ACF7-B9E75C086368Q30993697-ED298BBA-EE9A-4E93-B487-D2B9AF7D8B2EQ33354088-7A6CFFB2-DF8A-4C35-999A-CAAA8D3DD8A3Q33359369-E0B75C3F-1E52-40D0-90F0-B8142271B71CQ33588875-85B98F3A-CB9F-4DD3-9DFD-EF0E94CF32ECQ33681073-AF77E311-F0D0-43CB-82BD-294D37F4ED8BQ33693122-93533B3D-047D-479C-967F-07893F28D20CQ33826259-4B354651-804B-407A-BCFB-D4B776C5BD33Q33916720-412440F0-473A-4401-993C-42D397877195Q33923359-7B2BEA11-D534-4C66-9404-808F52FB5022Q34043151-6EA1A226-7792-4259-AB1E-A3082AFC8D62Q34102567-0AA95696-0EDE-4B5C-A17B-01A8DB77E81DQ34133158-3294A5CB-6737-4313-B35D-B50716B75BB4Q34164828-B11139EA-C802-46BE-A3C7-89087F6B5025Q34172317-ACBB0D7B-A7C9-4ED1-937F-9B09211971C3Q34211983-5A442906-257C-4F27-89D3-939909AC373AQ34270856-F05D5696-3A2F-4832-8C19-2D76A2CE10A7Q34341710-9361F143-6F9D-47FC-AB51-7AF37677624CQ34475490-842A39C4-8D13-4D32-BF82-0828E7E20B7EQ34721223-D0756558-1A22-40F3-B1B2-2EC0337D76E6Q34888501-3EF256F7-EA78-4D4F-AE35-8474F826B7ECQ34995163-980A1412-298F-4EAC-9A9B-B9FFA9A3062FQ35002899-766A6BB5-7CC4-47B5-9817-49848A9D0338Q35072458-8DB02DDB-2E9C-4E3A-99F7-B17CE4FD2BF0Q35094477-DF07642D-1461-4A2F-AF42-46AF5768014FQ35116144-F7128C0D-2A00-422B-8183-A96C228A0F5FQ35171136-AD07C859-182F-4303-B812-0C09F14BED91Q35222002-2807BBB4-6AA4-40FD-9D4F-1CF35E151E64
P2860
Systemic and cell type-specific gene expression patterns in scleroderma skin.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Systemic and cell type-specific gene expression patterns in scleroderma skin.
@ast
Systemic and cell type-specific gene expression patterns in scleroderma skin.
@en
type
label
Systemic and cell type-specific gene expression patterns in scleroderma skin.
@ast
Systemic and cell type-specific gene expression patterns in scleroderma skin.
@en
prefLabel
Systemic and cell type-specific gene expression patterns in scleroderma skin.
@ast
Systemic and cell type-specific gene expression patterns in scleroderma skin.
@en
P2093
P2860
P50
P356
P1476
Systemic and cell type-specific gene expression patterns in scleroderma skin.
@en
P2093
Deborah R Finlay
Jen-Tsan Chi
John Isaac Murray
M Kari Connolly
Michael L Whitfield
Timothy H McCalmont
P2860
P304
12319-12324
P356
10.1073/PNAS.1635114100
P407
P577
2003-10-06T00:00:00Z